Lützen Portengen Selected Research

Lützen Portengen Research Topics

Disease

28	Lung Neoplasms (Lung Cancer) 01/2024 - 04/2010
13	Neoplasms (Cancer) 12/2023 - 06/2010
4	Leukemia 01/2022 - 04/2010
4	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2013 - 06/2010
2	Cardiovascular Diseases (Cardiovascular Disease) 08/2023 - 11/2022
2	Occupational Asthma 02/2023 - 01/2023
2	Birth Weight (Birth Weights) 12/2020 - 03/2016
2	Heart Diseases (Heart Disease) 01/2020 - 02/2012
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2018 - 11/2012
2	Asthma (Bronchial Asthma) 01/2017 - 01/2017
2	Lymphoma (Lymphomas) 12/2013 - 06/2011
1	Myocardial Ischemia (Ischemic Heart Diseases) 05/2024
1	Chronic Obstructive Pulmonary Disease (COPD) 05/2024
1	COVID-19 04/2024
1	Abdominal Obesity 12/2023
1	Genomic Instability 10/2023
1	Pediatric Obesity 02/2023
1	Infertility (Sterility) 01/2023
1	Parkinson Disease (Parkinson's Disease) 01/2023
1	Pregnancy Complications 01/2023
1	Burns 11/2022
1	Pneumonia (Pneumonitis) 11/2022
1	Poisoning 03/2022
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022
1	Stroke (Strokes) 01/2020
1	Laryngeal Neoplasms (Laryngeal Cancer) 01/2020
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2020
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2020
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2018
1	Multiple Myeloma 01/2018
1	Rhinitis 01/2017
1	Mesothelioma 05/2016
1	Hypersensitivity (Allergy) 03/2016
1	Prostatic Neoplasms (Prostate Cancer) 09/2015
1	Chronic Disease (Chronic Diseases) 12/2013
1	Eczema 06/2011

Drug/Important Bio-Agent (IBA)

8	Coal (Coals)IBA 10/2023 - 01/2019
6	Benzene (Benzole)IBA 10/2023 - 04/2010
6	Vehicle Emissions (Emissions, Vehicle)IBA 10/2023 - 10/2010
6	CarbonIBA 01/2020 - 10/2010
5	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 10/2023 - 10/2010
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2010
5	AsbestosIBA 01/2020 - 11/2011
4	CarcinogensIBA 10/2023 - 10/2010
4	5-methylchryseneIBA 10/2023 - 01/2019
3	Silicon Dioxide (Silica)FDA LinkGeneric 01/2024 - 01/2020
3	ORALIT (ORS)IBA 01/2023 - 01/2017
3	fu-yuanIBA 01/2020 - 01/2019
3	Polychlorinated Dibenzodioxins (TCDD)IBA 12/2013 - 06/2011
3	asphaltIBA 03/2013 - 10/2010
2	DioxinsIBA 12/2023 - 11/2012
2	Persistent Organic PollutantsIBA 02/2023 - 12/2020
2	MetalsIBA 01/2023 - 10/2010
2	chromium hexavalent ionIBA 01/2023 - 01/2020
2	Air Pollutants (Pollutants, Air)IBA 01/2023 - 01/2019
2	SaltsIBA 01/2023 - 03/2016
2	NickelIBA 01/2023 - 01/2020
2	Benzo(a)pyreneIBA 01/2023 - 01/2019
2	Lobeline (Smokeless)IBA 11/2022 - 01/2020
2	Environmental Pollutants (Pollutants, Environmental)IBA 12/2020 - 01/2019
2	Dichlorodiphenyl Dichloroethylene (DDE)IBA 12/2020 - 03/2016
2	Polychlorinated Biphenyls (PCBs)IBA 12/2020 - 09/2015
2	CytokinesIBA 01/2018 - 06/2010
2	LipidsIBA 03/2016 - 09/2015
2	EndotoxinsIBA 04/2010 - 04/2005
1	Messenger RNA (mRNA)IBA 05/2024
1	antiarrhythmic peptide (AAP)IBA 04/2024
1	CholesterolIBA 12/2023
1	Triglycerides (Triacylglycerol)IBA 12/2023
1	Retroelements (Retrotransposon)IBA 10/2023
1	Hormones (Hormone)IBA 08/2023
1	IsocyanatesIBA 02/2023
1	phosphinothricin (Basta)IBA 01/2023
1	methylparaben FDA LinkGeneric 01/2023
1	vinclozolinIBA 01/2023
1	fluroxypyr methylheptyl esterIBA 01/2023
1	picoxystrobinIBA 01/2023
1	perfluoroundecanoic acidIBA 01/2023
1	Diethylhexyl Phthalate (DEHP)IBA 01/2023
1	LinuronIBA 01/2023
1	PesticidesIBA 01/2023
1	PlatinumIBA 01/2023
1	imidazole mustard (BIC)IBA 12/2020
1	PCB 180IBA 12/2020
1	RadonIBA 01/2020
1	Particulate MatterIBA 01/2019
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2018
1	ChemokinesIBA 01/2018
1	Disinfectants (Biocides)IBA 01/2017
1	discoidin-binding polysaccharideIBA 01/2017
1	AllergensIBA 01/2017
1	A-factor (Streptomyces)IBA 05/2016
1	oxychlordaneIBA 09/2015
1	InsecticidesIBA 09/2015
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2014
1	SmokeIBA 02/2014
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 12/2013
1	HerbicidesIBA 02/2012

Therapy/Procedure

1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 10/2021
1	AC protocol (CA protocol) 10/2021